Physician profile
Gundeep Singh
NPI 1972542108
$18,377.04
in general payments reported to CMS, 2019-2025
43 companies · $2,281 in 2025
The $2,281 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,301 · 2020: $1,664 · 2021: $2,581 · 2022: $5,038 · 2023: $2,053 · 2024: $2,460 · 2025: $2,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,794.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,319.16 | 2021-2025 | Micra, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $1,776.47 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,766.15 | 2019-2025 | Jardiance |
| Amgen INC. | $1,316.62 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,243.46 | 2019-2024 | Xarelto |
| Pfizer INC. | $1,156.24 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $773.69 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $572.45 | 2022-2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $539.71 | 2019-2025 | Wainua, Farxiga, Lokelma |
| Alnylam Pharmaceuticals INC. | $485.69 | 2022-2025 | Amvuttra, Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $468.23 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $422.69 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $379.07 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic Vascular, INC. | $313.00 | 2019-2020 | |
| Boston Scientific Corporation | $298.04 | 2019-2024 | Patientcare Link, Bodyguardian |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $258.47 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $253.79 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $242.91 | 2019-2024 | |
| Abbott Laboratories | $235.00 | 2019-2025 | Mitraclip, Triclip |
| Amarin Pharma, INC. | $208.52 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $197.49 | 2019-2021 | |
| Esperion Therapeutics, INC. | $195.77 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $193.44 | 2022-2025 | Assure Wcd |
| Novo Nordisk INC | $170.67 | 2024-2025 | Ozempic, Wegovy |
| Lexicon Pharmaceuticals, INC. | $157.92 | 2023-2024 | Inpefa |
| Astellas Pharma US INC | $156.44 | 2019-2022 | |
| Inspire Medical Systems, INC. | $153.24 | 2024-2025 | Inspire |
| Bardy Diagnostics, INC. | $150.00 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $143.61 | 2019-2021 | |
| Bridgebio Pharma, INC. | $140.92 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $116.22 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $102.84 | 2021-2023 | Arcalyst |
| Baxter Healthcare | $88.77 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lundbeck LLC | $78.83 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $62.22 | 2022-2024 | Edarbi, Edarbi |
| Regeneron Healthcare Solutions, INC. | $56.27 | 2019 | |
| Philips North America LLC | $48.51 | 2020 | |
| Cvrx, INC. | $47.53 | 2025 | Barostim Neo System |
| Irhythm Technologies, INC. | $30.13 | 2019-2020 | |
| Biohorizons Implant Systems INC. | $18.27 | 2025 | Biohorizons Dental Implants |
| Allergan, INC. | $13.32 | 2019 | |
| Itamar Medical INC | $12.64 | 2023 | Watchpatone |
| Medicomp INC | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gundeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.